These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26536674)

  • 1. [How anti-osteoporotic drugs work to improve bone metabolism].
    Takeuchi Y
    Nihon Rinsho; 2015 Oct; 73(10):1614-8. PubMed ID: 26536674
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-osteoporotic drugs and vascular calcification: the bidirectional calcium traffic.
    Yavropoulou MP; Pikilidou M; Yovos JG
    J Vasc Res; 2014; 51(1):37-49. PubMed ID: 24280985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
    Yamada S; Inaba M; Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():348-51. PubMed ID: 18161129
    [No Abstract]   [Full Text] [Related]  

  • 5. [New bone density conservation agents for osteoporosis under research and development: ED-71].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():454-8. PubMed ID: 18161148
    [No Abstract]   [Full Text] [Related]  

  • 6. [New bone density conservation agents for osteoporosis under research and development: Zoledronate].
    Wada S; Fukawa T; Kamiya S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():421-5. PubMed ID: 18161143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone micro-structural changes following osteoporotic drug treatment].
    Mori S
    Clin Calcium; 2013 Jul; 23(7):1027-33. PubMed ID: 23811592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect on bone structure and strength by novel anti-osteoporotic agents].
    Sone T
    Clin Calcium; 2013 Jul; 23(7):1021-6. PubMed ID: 23811591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological topics of bone metabolism. Preface.
    Togari A; Ohya K
    J Pharmacol Sci; 2008 Apr; 106(4):529. PubMed ID: 18431034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.
    Bonjour JP; Kohrt W; Levasseur R; Warren M; Whiting S; Kraenzlin M
    Nutr Res Rev; 2014 Dec; 27(2):252-67. PubMed ID: 25394580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination anabolic and antiresorptive therapy for osteoporosis.
    Cusano NE; Bilezikian JP
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current topics in pharmacological research on bone metabolism: preface.
    Furukawa K; Shinoda H
    J Pharmacol Sci; 2006 Mar; 100(3):187. PubMed ID: 16518077
    [No Abstract]   [Full Text] [Related]  

  • 16. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of SERMs on bone health. Changes in bone metabolism in cases of gender identity disorder].
    Miyajima T
    Clin Calcium; 2010 Mar; 20(3):380-7. PubMed ID: 20190368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-suppression of bone turnover: does it exist?
    Compston J
    Curr Osteoporos Rep; 2007 Dec; 5(4):179-85. PubMed ID: 18430393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deviations of calcium and phosphorus metabolism in postmenopausal osteoporosis].
    Yoshikawa S
    Nihon Rinsho; 1982; 40(12):2738-44. PubMed ID: 6761467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.